Find scientific studies on the medical usefulness of marijuana, CBD, and THC in our archive of medical cannabis research. Full articles are available via their respective publishers: sources and prices are noted.
This category contains links to studies providing an overview of Cannabis research to date as well as explorations and explanations of the human body’s endocannabinoid system, which is the chemical network that the Cannabis plant’s cannabinoids interact with. Studies in this section are an excellent place to catch up on your general Cannabis knowledge with concrete academic background.
Published via Acta Psychiatrica Scandinavica
Published via Pharmacological Reviews
Published via Expert Review of Neurotherapeutics
This section provides links to both general and specific studies relating to the research on the effects of cannabis on many facets of the cancer disease.
Published via Frontiers in Pharmacology
Published via Journal of Pharmacology and Experimental Therapeutics
Published via European Journal of Pharmacology
The academic studies in this section look at several possible clinical effects of cannabis on Epilepsy, via both recent work and meta-studies of older work. Cannabis has been demonstrated across many studies to have anti-convulsant and anti-seizure characteristics in certain animals, including humans.
Published via Frontiers in Pharmacology
Published via Author Manuscript
Published via Epilepsy Currents
The academic studies in this category explore the relationship between Cannabis and addiction. Various varieties of addiction were studied, including opioid, tobacco, alcohol and cannabis addiction.
Published via Addictive Behaviors
Published via Addiction Biology
Published via Research Communications in Chemical Pathology and Pharmacology
The studies in the Anorexia category examine Cannabinoid-based interactions with eating disorders such as Anorexia or Bulimia, as well as Anorexia induced by cancer and cancer treatments. These studies are primarily overviews and are a good place to begin research.
Published via Forsch Komplementarmed
Published via Journal of Psychiatric Research
Published via Current Pharmaceutical Design
The Arthritis section contains overviews of research on Cannabis as a treatment. Research as well as a long history of anecdotal reports indicate Cannabis has a pain-relieving effect on Arthritis. Cannabis is also known to be anti-inflammatory and the other primary and effective treatment for Arthritis is NSAIDs like Ibuprofen or Sodium Naproxen.
Published via Rheumatology
Published via Proceedings of the National Academy of Sciences of the United States of America
Published via Neuroscience Letters
This section deals with research relating to Cannabis and Attention Deficit Disorder (ADD) and Attention Deficit Hyperactivity Disorder (ADHD). Medical consensus is not well established about treating ADD/ADHD with Cannabis, so many of the studies attempt to understand which subtypes of ADD/ADHD are self-medicating with Cannabis and where they’re getting the information.
Published via Author Manuscript
Published via Journal of Clinical Psychopharmacology
Published via Substance Use & Misuse
The endocannabinoid system has been shown in research to be significantly intertwined with the same mind and body systems that malfunction in PTSD patients. Research has only just begun but to date PTSD seems to be one of the best candidates for medication with cannabis.
Published via Drug Testing and Analysis
Published via Current Pharmaceutical Design
Published via Journal of Psychiatric Research
Research indicates Cannabis has a large effect on both nausea and vomiting. Several traditional pharmacological drugs have been synthesized from THC and CBD that are commonly used to reduce nausea and vomiting due to chemotherapy, including in children.
Published via NeuroReport
Published via British Journal of Pharmacology
Published via British Journal of Pharmacology
The studies in this section deal with Diabetes and Cannabis. Research into treatment of Diabetes with Cannabis is only just beginning and most of the studies show a correlation but not the method of action. There is a correlation established in research that the rates of Diabetes and obesity in Cannabis users is lower than that of non-users, indicating there is some connection.
Published via The American Journal of Medicine
Published via Autoimmunity
Published via The American Journal of Pathology
Studies in this section deal with Cannabis and heart disease, as well as other cardiovascular effects. Research indicates that cannabis, especially CBD, has many useful effects on the cardiovascular system. Other cannabinoids also have been shown to have effects on many parts of the cardiovascular system.
Published via BMJ Publishing Group Limited
Published via Author Manuscript
Published via Journal of Cardiovascular Pharmacology and Therapeutics
The studies in this section deal with Cannabis’s effects on various emotional and mood systems in the body. The human endocannabinoid system, which Cannabis interacts with, is shown in research to be heavily involved in early neural development before birth and during adolescence, also considered to be key times for the development of emotional disorders and anxiety. Cannabis and the relevant body pathways are efficient ways to treat these problems.
Published via Neuropsychopharmacology
Published via Acta Psychiatrica Scandinavica
Published via Philosophical Transactions of the Royal Society B
The studies in this section deal with the body’s reaction to stress, which is centered around the endocannabinoid system. Cannabis interacts with this same pathway, so it seems inarguable that THC and CBD both would be ideal chemicals to treat a variety of stress-based diseases. The endocannabinoid pathways in the brain are the primary system that controls response to stress in the human body.
Published via Neuroscience & Biobehavioral Reviews
Published via Proceedings of the National Academy of Sciences of the United States of America
Published via Author Manuscript
This section deals with Liver Disease and the endocannabinoid pathways, which are modulated by Cannabis. Though the adult liver does not contain many cannabinoid signaling sites, there is a proven correlation of Cannabis and liver health, especially among those who have alcohol damaged livers or other non-alcoholic induced liver diseases such as Hepatitis.
Published via Journal of Neuroendocrinology
Published via Cell Death & Disease
Published via European Journal of Pharmacology
Research concerning Cannabis, endocannabinoids and Schizophrenia and other psychotic disorders are contained in this section. Recent research has revealed the balance-maintaining purpose of the body’s cannabinoid system plays a major role in Schizophrenia. Some research has revealed that certain cannabinoids, like THC, can cause psychotic episodes, while others -- like CBD -- can prevent or lessen the symptoms of schizophrenia.
Published via Current Pharmaceutical Design
Published via Neuropsychopharmacology
Published via European Neuropsychopharmacology
This category concerns the research regarding Cannabis and Multiple Sclerosis (MS). Cannabis’s effects on MS are very positive. Sativex, a CBD:THC combined oral spray, has been tested extensively in clinical conditions with very positive results for muscle control and spasticity in sufferers of MS.
Published via Clinical Therapeutics
Published via Neurological Research
Published via Journal of Neurology
This section deals with studies pertaining to Cannabis and Parkinson’s Disease. Basic research has been done to determine if cannabinoids have a role to play in treatment of Parkinson’s, though the specific methods of actions and particular cannabinoids have not yet been identified.
Published via Brain Research
Published via Neurobiology of Disease
Published via British Journal of Pharmacology
Franco Brockelman is the CEO and co-founder of Releaf App, a digital cannabis journal that enables users to record and… Read More
Danny Sloat is the owner of Alpinstash, a Colorado cannabis cultivator known for producing premium-quality cannabis with an emphasis on… Read More
Fri / Nov 22nd
The U.S. Food and Drug Administration (FDA) this week approved a clinical trial to investigate whether smoking or vaping medical… Read More
Wed / Nov 20th
Georgia medical cannabis operators are opening additional dispensaries after the medical cannabis program’s total patient count recently reached 25,000 patients,… Read More
Mon / Nov 18th
Chronic pain is the most common reason for medical cannabis use, according to a new report from virtual cannabis clinic… Read More
Fri / Nov 8th
Kentucky voters in 53 cities and 53 counties this week considered ballot initiatives to allow local medical cannabis operations. In… Read More
Wed / Nov 6th
Voters in Nebraska on Tuesday passed medical cannabis reforms with voters approving the legalization measure 71% to 29% and the regulation… Read More
Mon / Nov 4th
Virginia has tabbed Metrc as its cannabis seed-to-sale tracking software, the company announced last week. Metrc now has 27 government… Read More
Mon / Nov 4th
A district court judge in Nebraska ruled that despite a last-minute legal challenge to the state’s medical cannabis legalization bid… Read More
Website & branding by the Ganjapreneur in-house agency:
Uplifted cannabis industry branding & marketing.